In 2017, a subagency of the National Institutes of Health (NIH) – headed by Dr. Anthony Fauci – resumed funding a controversial grant to genetically modify bat coronaviruses in Wuhan, China without the approval of a government oversight body, according to the Daily Caller.
- Tyler Durden
For context, in 2014, the Obama administration temporarily suspended federal funding for gain-of-function research into manipulating bat COVID to be more transmissible to humans. Four months prior to that decision, the NIH effectively shifted this research to the Wuhan Institute of Virology (WIV) via a grant to nonprofit group EcoHealth Alliance, headed by Peter Daszak.
The first $666,442 installment of EcoHealth’s $3.7 million NIH grant was paid in June 2014, with similar annual payments through May 2019 under the “Understanding The Risk Of Bat Coronavirus Emergence” project.
Notably, the WIV “had openly participated in gain-of-function research in partnership with U.S. universities and institutions” for years under the leadership of Dr. Shi ‘Batwoman’ Zhengli, according to the Washington Post‘s Josh Rogin.
In 2017, however, the “Potential Pandemic Pathogens Control and Oversight (P3CO) Framework was formed within the Department of Health and Human Services (HHS),” which was tasked with evaluating the risks involved with enhancing dangerous pathogens, as well as whether proper safeguards are in place, before a grant into ‘gain-of-function’ or similarly risky research can be issued.
Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) – the subagency which funded EcoHealth – didn’t think the grant needed review, and resumed their relationship with Daszak without flagging it for the P3CO committee, an NIH spokesperson told the Caller. …